Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies

Yerel katalogda bu makaleye atıf yapan 53 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

1. 2024 Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesteraseAtıf 72 · OpenAlex
2. 2024 Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesteraseAtıf 72 · OpenAlex
3. 2024 Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesteraseAtıf 72 · OpenAlex
4. 2024 Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesteraseAtıf 72 · OpenAlex
5. 2024 Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesteraseAtıf 72 · OpenAlex
6. 2025 Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activityAtıf 60 · OpenAlex
7. 2025 Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activityAtıf 57 · OpenAlex
8. 2025 Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activityAtıf 57 · OpenAlex
9. 2025 Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activityAtıf 57 · OpenAlex
10. 2025 Development of phenolic Mannich bases as α-glucosidase and aldose reductase inhibitors: In vitro and in silico approaches for managing diabetes mellitus and its complicationsAtıf 45 · OpenAlex